BWL
TTNP

Bogart Wealth LLC’s Titan Pharmaceuticals TTNP Stock Holding History

Bogart Wealth LLC’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 1824

Other funds holding TTNP

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Bogart Wealth LLC's TTNP Position: Q1 2026 in Review

Bogart Wealth LLC opened a new position in Titan Pharmaceuticals (TTNP) in Q1 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #1824 among its holdings.

6 funds tracked by Wall St. Rank hold TTNP as of Q1 2026.

  • Bogart Wealth LLC held 1 share of Titan Pharmaceuticals worth $1 as of Q1 2026.
  • Titan Pharmaceuticals was a new Bogart Wealth LLC position in Q1 2026.
  • Titan Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q1 2026, its #1824 holding.
  • 6 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q1 2026.

Based on Bogart Wealth LLC's 13F filing for Q1 2026, filed 28 Apr 2026.